|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 982.50 INR | -0.05% |
|
-1.11% | -13.72% |
| Capitalization | 38TCr 435.36Cr 377.19Cr 353.77Cr 322.46Cr 597.78Cr 676.28Cr 4.19TCr 1.61TCr 17TCr 1.63TCr 1.6TCr 64TCr | P/E ratio 2025 * |
65.3x | P/E ratio 2026 * | 58.1x |
|---|---|---|---|---|---|
| Enterprise value | 38TCr 434.75Cr 376.67Cr 353.28Cr 322.01Cr 596.94Cr 675.34Cr 4.19TCr 1.61TCr 17TCr 1.63TCr 1.6TCr 64TCr | EV / Sales 2025 |
11.2x | EV / Sales 2026 * | 11.5x |
| Free-Float |
39.87% | Yield 2025 * |
-
| Yield 2026 * | - |
More valuation ratios
* Estimated data
More news
Last Transcript: Cohance Lifesciences Limited
| 1 day | -0.05% | ||
| 1 week | -1.11% | ||
| Current month | -6.22% | ||
| 1 month | -9.75% | ||
| 3 months | -18.89% | ||
| 6 months | -13.06% | ||
| Current year | -13.72% |
| 1 week | 975.9 |  | 1,020.5 |
| 1 month | 974.9 | | 1,119 |
| Current year | 935 | | 1,328 |
| 1 year | 700 | | 1,360 |
| 3 years | 390.5 | | 1,360 |
| 5 years | 223 | | 1,360 |
| 10 years | 87.6 | | 1,360 |
| Manager | Title | Age | Since |
|---|---|---|---|
Sudhir Singh
CEO | Chief Executive Officer | - | 29/09/2023 |
| Director of Finance/CFO | 31 | 01/01/2024 | |
Kundan Kumar Jha
CMP | Compliance Officer | - | 03/09/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | - | 29/09/2023 | |
Pankaj Patwari
BRD | Director/Board Member | - | 29/09/2023 |
| Director/Board Member | 67 | 29/09/2023 |
| Name | Weight | AuM | 1st Jan change | |
|---|---|---|---|---|
| 0.01% | 89 M€ | -2.93% | - |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.05% | -1.11% | +37.62% | +109.80% | 434.08Cr | ||
| +0.35% | -2.25% | -13.11% | +137.52% | 69TCr | ||
| +0.55% | -0.18% | +2.01% | -16.56% | 36TCr | ||
| +0.52% | -0.40% | +6.94% | +21.26% | 32TCr | ||
| +0.53% | -7.16% | -54.16% | +15.24% | 31TCr | ||
| +0.61% | +0.19% | +2.62% | -17.79% | 26TCr | ||
| +0.36% | -0.16% | -0.61% | +18.39% | 23TCr | ||
| -0.84% | -3.10% | -17.20% | -4.12% | 22TCr | ||
| -0.65% | +1.19% | -40.42% | -14.94% | 20TCr | ||
| +1.91% | -4.23% | -12.69% | +13.21% | 15TCr | ||
| Average | +0.33% | -4.31% | -8.90% | +26.20% | 27.47TCr | |
| Weighted average by Cap. | +0.36% | -5.02% | -13.07% | +36.00% |
| 2025 | 2026 * | |
|---|---|---|
| Net sales | 2.59TCr 30Cr 26Cr 24Cr 22Cr 41Cr 46Cr 287.75Cr 110.66Cr 1.19TCr 112.09Cr 109.71Cr 4.37TCr | 3.26TCr 38Cr 33Cr 31Cr 28Cr 52Cr 58Cr 362.41Cr 139.38Cr 1.49TCr 141.18Cr 138.17Cr 5.51TCr |
| Net income | 585.57Cr 6.76Cr 5.86Cr 5.5Cr 5.01Cr 9.29Cr 11Cr 65Cr 25Cr 268.67Cr 25Cr 25Cr 989.84Cr | 728.2Cr 8.41Cr 7.29Cr 6.83Cr 6.23Cr 12Cr 13Cr 81Cr 31Cr 334.11Cr 32Cr 31Cr 1.23TCr |
| Net Debt | -53Cr -60.81L -52.68L -49.41L -45.04L -83.49L -94.46L -5.86Cr -2.25Cr -24Cr -2.28Cr -2.23Cr -89Cr | -247.5Cr -2.86Cr -2.48Cr -2.32Cr -2.12Cr -3.92Cr -4.44Cr -28Cr -11Cr -113.56Cr -11Cr -10Cr -418.37Cr |
More financial data
* Estimated data
Employees
1,193
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 24/25/24 | 985.40 ₹ | +0.30% | 62,496 |
| 23/25/23 | 982.50 ₹ | -0.05% | 1,91,635 |
| 20/25/20 | 983.00 ₹ | -0.78% | 10,26,900 |
| 19/25/19 | 990.70 ₹ | -1.87% | 1,32,445 |
| 18/25/18 | 1,009.60 ₹ | +1.46% | 5,34,042 |
End-of-day quote NSE India S.E., June 23, 2025
More quotes
Sell
Buy
Mean consensus
BUY
Number of Analysts
6
Last Close Price
982.50INR
Average target price
1,313.00INR
Spread / Average Target
+33.64%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- COHANCE Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition